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Source/Description: Clone WT33 contains a 2.3 kb cDNA of
one of the candidate genes for Wilms' tumor at lI p13 (1). A
1.8 kb EcoRI fragment of the plasmid was used as a probe, which
covered the 5' portion of the gene.
Polymorphisms: TaqI detected two 2-allele polymorphisms (set
Aa and Ab) with fragment size of 3.4 kb (Al) or 3.2 kb (A2),
and 2.2 kb (Al) or 1.5 kb (A2). Constant bands of 6.6, 3.7,
1.7, 1.2 and 0.8 kb were also detected.
Frequencies: Studied in 65 unrelated individuals of the normal
Japanese (2). Frequencies of haplotype were estimated with the
aid of tumor DNAs with loss of heterozygosity.
Set Alleles Set Alleles
Aa A1 = .88 Ab Al = .14 albl = .02
A2 = .12 A2 = .86 alb2 = .86
a2 bl = .12
a2 b2 = .00
Mendelian Inheritance: Co-dominant segregation was confirmed
in 15 two-generation families.
Other Comments: The above two polymorphisms seemed to be
in linkage disequilibrium. The polymorphism was also observed
in the Wilms' patients with the allelic frequencies being similar.
Therefore, a particular allele seemed not to associate with genesis
of the tumor. Nevertheless, this polymorphism was useful to
detect loss of allele at the locus.
Acknowledgements: We thank Dr.D.E.Housman for kindly
providing us with the probe. K.T. and K.M. are recipients of
Research Fellowships from the Foundation for Promotion of
Cancer Research and the Human Science Foundation, Japan,
respectively. This study was supported by Grants-in-Aid for
Scientific Research from Ministry of Health and Welfare for the
Comprehensive 10-year Strategy for Cancer Control, Japan.
References: I)Call,K.M., Glaser,T., Ito,C.Y., Buckler,A.J.,
Pelletier,J., Harber,D.A., Rose,E.A., Kral,A., Yeger,H.,
Lewis,W.H., Jones,C. and Housman,D.E. (1990) Cell 60,
509-520. 2)Kurosawa,H., Yamada,M. and Nakagome,Y.
(1987) Oncogene 2, 85-90. s" - ...A
g3R3S.-.
Mspl RFLP detected by a ZNF-40
cDNA sequence
Jane W.Fountain, Nicholas C.Dracopoli,
David E.Housman and Albert S.Baldwin1
Center for Cancer Research, MIT, Cambridge, MA 02139
and 1213 Lineberger Research Center and Department of
Biology, UNC, Chapel Hill, NC 27599, USA
Source/Description: 1.6 kb EcoRI fragment from a 5' cDNA
clone (designated 4b) of the human ZNF-40 locus. ZNF-40
(MBP-1) (PRDII-BFI) encodes the class I major
histocompatibility complex (MHC) enhancer binding protein 1
(2).
Polymorphism: MspI digestion of genomic DNA and
hybridization with this probe reveals a two-allele polymorphism
with fragment sizes of 1.60 kb (Al) and 1.85 kb (A2). Two
additional faint constant bands of 1.90 kb and 0.5 kb are also
detected by this probe.
Frequency: Allele frequencies were determined from 94 unrelated
individuals, including 79 CEPH parent DNAs. Al = 0.26 A2
= 0.74
Not Polymorphic For: BanH and HindIll (2 4 individuals
screened).
Chromosomal Location: Initial localization to chromosome 6 was
determined using somatic cell hybrids, followed by more precise
assignment to 6p23 -24 using in situ and multipoint mapping
techniques (3).
Mendelian Inheritance: Co-dominant segregation was observed
in 21 informative CEPH families (248 individuals) (3).
Probe Availability: Request for probe to Dr.A.S.Baldwin at the
above address.
Other Comments: This RFLP was observed under normal
hybridization and washing (i.e. 0.1 x SSC 0.1 % SDS at 65°C
for 15 minutes) conditions. A reduction in stringency is not
recommended when using this probe due to the presence of a
related gene/pseudogene in the genome (2).
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